Literature DB >> 2502837

Ciprofloxacin versus amoxycillin and probenecid in the treatment of uncomplicated gonorrhoea.

A Lassus1, L Karppinen, L Ingervo, L Jeskanen, S Reitamo, H P Happonen, R Karkulahti.   

Abstract

In a randomized study 100 patients, 78 males and 22 females, with uncomplicated gonorrhoea were treated with either a single oral dose of 250 mg of ciprofloxacin or a single oral dose of 3 g of amoxycillin and 1 g of probenecid. Three of the gonococcal strains produced penicillinase and, in addition, nine strains had MIC-values of amoxycillin ranging between 0.6 and 1.2 mg/l and five other strains MIC-values higher than 1.2 mg/l. Twenty-two patients had a concomitant infection due to Chlamydia trachomatis. All patients treated with ciprofloxacin were cured, while two patients treated with amoxycillin had treatment failures. Neither treatment regimen had any effect on the chlamydial infections. No adverse effects were observed. It was concluded that ciprofloxacin is the drug of choice in the treatment of uncomplicated infections due to Neisseria gonorrhoeae.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2502837

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  3 in total

1.  Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.

Authors:  H D Davies; E E Wang
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

2.  Pefloxacin and ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in males [corrected].

Authors:  L L Cheong; R K Chan; M Nadarajah
Journal:  Genitourin Med       Date:  1992-08

3.  Efficacy and Safety of Injectable and Oral Antibiotics in Treating Gonorrhea: A Systematic Review and Network Meta-Analysis.

Authors:  Jiaru Yang; Subhash Dhital; Thomas Naderer
Journal:  J Clin Med       Date:  2019-12-11       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.